BioMed Realty Trust Appoints Janice L. Sears, Former Bank of America Executive, to its Board of Directors

     BioMed Realty Trust Appoints Janice L. Sears, Former Bank of America
                     Executive, to its Board of Directors

PR Newswire

SAN DIEGO, April 9, 2014

SAN DIEGO, April 9, 2014 /PRNewswire/ --BioMed Realty Trust, Inc. (NYSE: BMR)
today announced the appointment of Janice L. Sears, an experienced executive,
investment banker and commercial real estate expert, to its board of

BioMed Realty Trust Logo

"We are very excited to add Janice Sears to our board," said Alan D. Gold,
Chairman and Chief Executive Officer of BioMed Realty. "BioMed Realty will
benefit from Janice's expertise in commercial real estate and investment
banking as we continue our path to grow as the leading provider of real estate
to the life science industry."

For over 20 years, Ms. Sears worked at Bank of America as a senior leader in
its San Francisco office, including as Managing Director, Western Region Head
in the Real Estate, Gaming & Lodging Investment Banking Group at Banc of
America Securities. In that position, she managed a team that originated and
executed equity, mergers & acquisitions and debt products. She concurrently
served as San Francisco Market President for Bank of America, where she worked
to deepen relationships and build the brand for Bank of America with
non-profit organizations and local governments. Before this role, Ms. Sears
was Head of Client Management for Bank of America's Commercial Real Estate
Group in California, where she oversaw client relationships with REITs,
homebuilders and opportunity funds.

Mr. Gold added, "We will look to leverage Janice's extensive knowledge and
experience in the commercial real estate market to build on and enhance our
strategy to grow in key life science cluster markets and capitalize on new
opportunities like our recent announcement with Yale University in New Haven,

Ms. Sears received Bachelor of Science degrees in Economics and Business
Administration from the University of Delaware. She currently serves on the
board of directors, audit and capital markets committees of Essex Property
Trust, Inc., a publicly traded REIT. She also serves as chair of the board of
directors of The Swig Company, a privately held owner of office properties

About BioMed Realty Trust

BioMed Realty, with its trusted expertise and valuable relationships, delivers
optimal real estate solutions for biotechnology and pharmaceutical companies,
scientific research institutions, government agencies and other entities
involved in the life science industry. BioMed Realty owns or has interests in
properties comprising approximately 17.3 million rentable square feet.
Additional information is available at

This press release contains forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995 based on current
expectations, forecasts and assumptions that involve risks and uncertainties
that could cause actual outcomes and results to differ materially. These risks
and uncertainties include, without limitation: general risks affecting the
real estate industry (including, without limitation, the inability to enter
into or renew leases, dependence on tenants' financial condition, and
competition from other developers, owners and operators of real estate);
adverse economic or real estate developments in the life science industry or
the company's target markets; risks associated with the availability and terms
of financing, the use of debt to fund acquisitions, developments and other
investments, and the ability to refinance indebtedness as it comes due;
failure to maintain the company's investment grade credit ratings with the
ratings agencies; failure to manage effectively the company's growth and
expansion into new markets, or to complete or integrate acquisitions and
developments successfully; reductions in asset valuations and related
impairment charges; risks and uncertainties affecting property development and
construction; risks associated with tax credits, grants and other subsidies to
fund development activities; risks associated with downturns in foreign,
domestic and local economies, changes in interest rates and foreign currency
exchange rates, and volatility in the securities markets; ownership of
properties outside of the United States that subject the company to different
and potentially greater risks than those associated with the company's
domestic operations; risks associated with the company's investments in loans,
including borrower defaults and potential principal losses; potential
liability for uninsured losses and environmental contamination; risks
associated with the company's potential failure to qualify as a REIT under the
Internal Revenue Code of 1986, as amended, and possible adverse changes in tax
and environmental laws; and risks associated with the company's dependence on
key personnel whose continued service is not guaranteed. For a further list
and description of such risks and uncertainties, see the reports filed by the
company with the Securities and Exchange Commission, including the company's
most recent annual report on Form 10-K and quarterly reports on Form 10-Q. The
company disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise.

Logo -

SOURCE BioMed Realty Trust, Inc.

Contact: Rick Howe, Senior Director, Corporate Communications, (858) 207-5859,
Press spacebar to pause and continue. Press esc to stop.